Form 4: GoodRx Director Ian Clark Exercises Stock Units, Increases Direct Equity Stake

GoodRx Holdings, Inc. Director Ian T Clark exercised 17,248 restricted stock units, acquiring Class A Common Stock, and now directly owns 100,150 shares.

Summary

• Ian T Clark, a Director of GoodRx Holdings, Inc. (GDRX), completed a transaction on July 8, 2025.
• The transaction involved the exercise of 17,248 Restricted Stock Units (RSUs).
• As a result of the exercise, 17,248 shares of Class A Common Stock were acquired at an exercise price of $4.74 per share.
• Following this transaction, Ian T Clark directly beneficially owns 100,150 shares of Class A Common Stock.
• Ian T Clark also holds 34,497 remaining Restricted Stock Units.
• The Restricted Stock Units vest as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on July 8, 2025, subject to continued service with the Issuer.

Sentiment

Score: 7

Explanation: The transaction involves a director increasing their direct beneficial ownership through the exercise of Restricted Stock Units, which is generally viewed as a positive signal of insider confidence, although it is a pre-scheduled vesting event rather than a discretionary open market purchase.

Positives

• A Director, Ian T Clark, increased his direct beneficial ownership of Class A Common Stock by 17,248 shares, bringing his total direct holdings to 100,150 shares.
• The exercise of Restricted Stock Units (RSUs) indicates a vesting event, converting contingent rights into actual equity, which can be seen as a positive step in insider ownership.

Negatives

• No explicit negatives are detailed in this Form 4 filing, which primarily reports a change in beneficial ownership.

Risks

• No specific risks are detailed in this Form 4 filing.

Future Outlook

Remaining Restricted Stock Units (34,497) are scheduled to vest in one-third increments on each of the first three anniversaries of the grant date, beginning July 8, 2025, contingent on continued service.

Management Comments

• No direct management comments or quotes are provided in this Form 4 filing.

Industry Context

This Form 4 filing details an insider transaction for GoodRx Holdings, Inc., and does not provide broader industry context or trends.

Comparison to Industry Standards

• Not applicable as this document is a Form 4 detailing an insider transaction, not a financial performance report.

Related Party Transactions

• The transaction involves Ian T Clark, a Director of GoodRx Holdings, Inc., exercising Restricted Stock Units and acquiring Class A Common Stock, which is a related party transaction.

Stakeholder Impact

• Shareholders may view the increase in direct beneficial ownership by a Director as a positive signal of confidence in the company's future.

Next Steps

• Future vesting of the remaining 34,497 Restricted Stock Units on the first three anniversaries of the grant date, starting July 8, 2025.

Key Dates

Keywords

GoodRx, GDRX, Form 4, Insider Transaction, Restricted Stock Units, Equity, Beneficial Ownership, Director